These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 21410724

  • 1. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK, Chen FC, Rea RF, Asirvatham SJ, Powell BD, Friedman PA, Shen WK, Brady PA, Bradley DJ, Lee HC, Hodge DO, Slusser JP, Hayes DL, Cha YM.
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [Abstract] [Full Text] [Related]

  • 2. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.
    J Am Coll Cardiol; 2010 May 25; 55(21):2376-82. PubMed ID: 20488310
    [Abstract] [Full Text] [Related]

  • 3. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
    Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M.
    Pacing Clin Electrophysiol; 2010 Apr 25; 33(4):400-6. PubMed ID: 20180915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD, Johnson JA, Turpie AG.
    Arch Intern Med; 2004 Jun 28; 164(12):1319-26. PubMed ID: 15226166
    [Abstract] [Full Text] [Related]

  • 6. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO, Lal L, Brown EN, Braun UK.
    J Clin Pharm Ther; 2007 Feb 28; 32(1):21-9. PubMed ID: 17286786
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
    Schulman S, Healey JS, Douketis JD, Delaney J, Morillo CA.
    Thromb Res; 2014 Oct 28; 134(4):814-8. PubMed ID: 25127655
    [Abstract] [Full Text] [Related]

  • 10. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.
    Am Heart J; 2009 Aug 28; 158(2):252-6. PubMed ID: 19619702
    [Abstract] [Full Text] [Related]

  • 11. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S, Bennett D, Smith DJ.
    Am J Cardiovasc Drugs; 2010 Aug 28; 10(1):37-48. PubMed ID: 20104933
    [Abstract] [Full Text] [Related]

  • 12. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
    Chen HC, Chen YL, Guo BF, Tsai TH, Chang JP, Pan KL, Lin YS, Chen MC.
    Can J Cardiol; 2013 Sep 28; 29(9):1110-7. PubMed ID: 23474139
    [Abstract] [Full Text] [Related]

  • 13. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 28; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 14. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S, Ford M, Rindone J.
    J Pharm Pract; 2011 Oct 28; 24(5):494-7. PubMed ID: 22156711
    [Abstract] [Full Text] [Related]

  • 15. Risk of thromboembolism with short-term interruption of warfarin therapy.
    Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM.
    Arch Intern Med; 2008 Jan 14; 168(1):63-9. PubMed ID: 18195197
    [Abstract] [Full Text] [Related]

  • 16. Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin.
    Blasdale C, Lawrence CM.
    Br J Dermatol; 2008 Mar 14; 158(3):522-6. PubMed ID: 18241270
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.
    Ann Pharmacother; 2011 Jul 14; 45(7-8):881-7. PubMed ID: 21750309
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
    Jennings JM, Robichaux R, McElderry HT, Plumb VJ, Gunter A, Doppalapudi H, Osorio J, Yamada T, Kay GN.
    J Cardiovasc Electrophysiol; 2013 Oct 14; 24(10):1125-9. PubMed ID: 23889767
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, Sirbu V, Bass TA, Della Rovere F, Gavazzi A, Angiolillo DJ.
    Am J Cardiol; 2008 Dec 15; 102(12):1618-23. PubMed ID: 19064015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.